论文部分内容阅读
目的对小儿支原体肺炎患儿采用莫西沙星联合阿奇霉素进行治疗,分析其临床治疗效果。方法选取临颍县人民医院2010年1月至2015年5月接收治疗的240例小儿支原体肺炎按治疗方式不同随机分为对照组和治疗组,每组各120例,对照组采用阿奇霉素进行治疗,治疗组患者在此基础上加用莫西沙星进行治疗,治疗后比较两组患儿的咳嗽消失时间、肺部罗音消失时间、退热时间以及治疗总有效率。结果治疗后,治疗组患儿的咳嗽消失时间、肺部罗音消失时间以及退热时间分别为(4.74±0.51)d、(4.11±0.47)d、(1.99±0.49)d,显著优于对照组的(5.17±0.62)d、(4.82±0.46)d、(2.71±0.13)d,差异具有统计学意义(P<0.05)。治疗组总有效率达90.83%,对照组总有效率为75%,两组差异具有统计学意义(P<0.05)。结论小儿支原体肺炎可采用莫西沙星联合阿奇霉素进行治疗,其治疗疗效显著,可显著提高患儿症状改善速度,具有一定的临床推广应用价值。
Objective To treat children with mycoplasma pneumonia by moxifloxacin combined with azithromycin and analyze its clinical effect. Methods 240 cases of Mycoplasma pneumoniae pneumonia received by Linying People’s Hospital from January 2010 to May 2015 were randomly divided into control group and treatment group according to different treatment methods, 120 cases in each group. The control group was treated with azithromycin, The patients in the treatment group were treated with moxifloxacin. After treatment, the disappearance of cough, the time of pulmonary rales disappearance, the time of fever relief and the total effective rate were compared between the two groups. Results After treatment, the disappearance of cough, the disappearance of pulmonary rales, and the duration of fever were 4.74 ± 0.51 days and 4.11 ± 0.47 days in the treatment group, respectively (1.99 ± 0.49) d, which were significantly better than those in the control Group (5.17 ± 0.62) d, (4.82 ± 0.46) d, (2.71 ± 0.13) d, the difference was statistically significant (P <0.05). The total effective rate was 90.83% in the treatment group and 75% in the control group, with statistical significance (P <0.05). Conclusion Mycoplasma pneumonia in children can be treated with moxifloxacin combined with azithromycin, the treatment effect is significant, can significantly improve the rate of improvement of symptoms in children with a certain clinical application value.